M&A Deal Summary

Hermed Capital Acquires DiaMedica

On July 18, 2016, growth capital firm Hermed Capital acquired life science company DiaMedica for 4M USD

Acquisition Highlights
  • This is Hermed Capital’s 2nd transaction in the Life Science sector.
  • This is Hermed Capital’s largest (disclosed) transaction.
  • This is Hermed Capital’s 3rd transaction in the United States.
  • This is Hermed Capital’s 1st transaction in Minnesota.

M&A Deal Summary
Date 2016-07-18
Target DiaMedica
Sector Life Science
Buyer(s) Hermed Capital
Deal Type Going Private
Deal Value 4M USD

Target

DiaMedica

Minneapolis, Minnesota, United States
DiaMedica is a clinical stage biopharmaceutical company focused on the development of novel, first-in-class therapies for metabolic disorders, kidney dysfunction and orphan diseases. DiaMedica was founded in 2000 and is based in Minneapolis, Minnesota.

Search 200,197 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Hermed Capital

Category Growth Capital Firm
Founded 2015
Size Small
Type Sector Focused
DESCRIPTION

Hermed Capital is a private investment firm focused on the healthcare sector. Specific areas of interest include pharmaceuticals, medical devices & diagnostics, and medical services. Hermed Capital was formed in 2015 and is headquartered in Shanghai

DEAL STATS #
Overall 3 of 7
Sector (Life Science) 2 of 5
Type (Going Private) 1 of 1
State (Minnesota) 1 of 1
Country (United States) 3 of 6
Year (2016) 2 of 2
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-06-06 Applied StemCell

Milpitas, California, United States

Applied StemCell is a biotechnology company. ASC offers an optimized series of tools for basic research study, drug discovery, bio-processing, bio-production and preclinical applications. Applied StemCell was established in 2008 and is based in Milpitas, California.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-04-28 Epic Sciences

San Diego, California, United States

Epic Sciences is a developer of novel diagnostics to personalize and advance the treatment and management of cancer. Epic’s mission is to enable the rapid and non-invasive detection of genetic and molecular changes in cancer throughout a patient’s journey. Epic Sciences was founded in 2008 and is based in San Diego, California.

Buy -
Mergr

Product

Company

Legal